One patient had a complete pathologic response (pCR) at surgery with no residual tumor tissue available while another patient had pT1mi disease resulting in material insufficient for repeat HER1–4 testing, resulting in paired pre- and post-NET tumor HER1–4 tumor assessments for 35 patients. This evidence concerns the gene EGFR and neoplasm.